Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India.

MLA

Ranade, A. A., et al. “Clinical and Economic Implications of the Use of Nanoparticle Paclitaxel (Nanoxel) in India.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 24 Suppl 5, Sept. 2013, pp. v6–12. EBSCOhost, https://doi.org/10.1093/annonc/mdt322.

APA

Ranade, A. A., Joshi, D. A., Phadke, G. K., Patil, P. P., Kasbekar, R. B., Apte, T. G., Dasare, R. R., Mengde, S. D., Parikh, P. M., Bhattacharyya, G. S., & Lopes, G. L. (2013). Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 24 Suppl 5, v6–v12. https://doi.org/10.1093/annonc/mdt322

Chicago

Ranade, A A, D A Joshi, G K Phadke, P P Patil, R B Kasbekar, T G Apte, R R Dasare, et al. 2013. “Clinical and Economic Implications of the Use of Nanoparticle Paclitaxel (Nanoxel) in India.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 24 Suppl 5 (September): v6–12. doi:10.1093/annonc/mdt322.